Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BenQ Medical TechnologyROCO:4116 -1.04%81 EBITDA Margin % is 13.19% as of Dec. 2025, which is 4% above its 10-year median of 12.66. GuruFocus rates ROCO:4116 with a GF Score™ of 81/100 and a GF Value™ of NT$62.38 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 816 Medical Devices & Instruments companies, BenQ Medical Technology ranks better than 59.8% on this metric.
BenQ Medical Technology (ROCO:4116) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
BenQ Medical Technology EBITDA Margin % Related Terms
BenQ Medical Technology EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4116 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, BenQ Medical Technology's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BenQ Medical Technology EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BenQ Medical Technology's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where BenQ Medical Technology's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BenQ Medical Technology (ROCO:4116) has a EBITDA Margin % of 13.19% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on BenQ Medical Technology and its competitors. This is near median its historical median of 12.66. Over the past decade, BenQ Medical Technology's EBITDA Margin % has ranged from 10.48 to 15.73. According to the industry distribution chart, BenQ Medical Technology ranks #328 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 40.2%.
Is BenQ Medical Technology's EBITDA Margin % too high?
BenQ Medical Technology's current EBITDA Margin % of 13.19% is near median its 10-year median of 12.66. Over the past 10 years, this metric has ranged from a low of 10.48 to a high of 15.73. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. BenQ Medical Technology's value of 13.19% is 76.5% above this industry median. Based on the distribution chart, BenQ Medical Technology ranks #328 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, BenQ Medical Technology has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BenQ Medical Technology's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, BenQ Medical Technology ranks #328 out of 816 companies for EBITDA Margin %. This puts BenQ Medical Technology in the upper half of its industry. The industry median EBITDA Margin % is 7.48. BenQ Medical Technology's value of 13.19% is 76.5% above this benchmark. Historically, BenQ Medical Technology's own EBITDA Margin % has ranged from 10.48 to 15.73 over the past decade. While the company's 10-year median is 12.66 vs. the industry median of 7.48, BenQ Medical Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BenQ Medical Technology's current EBITDA Margin % of 13.19% is 76.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on BenQ Medical Technology and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BenQ Medical Technology's current EBITDA Margin % is 13.19%, which is near median its own 10-year median of 12.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BenQ Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, BenQ Medical Technology (ROCO:4116) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$62.38, compared to a current price of NT$38.20 — trading 38.8% below its estimated fair value. The current EBITDA Margin % is 13.19%, which is near median its 10-year median of 12.66 and 76.5% above the Medical Devices & Instruments industry median of 7.48. BenQ Medical Technology's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For BenQ Medical Technology (ROCO:4116), the current EBITDA Margin % is 13.19% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BenQ Medical Technology (ROCO:4116) Overvalued in 2026?
Based on GuruFocus' analysis, BenQ Medical Technology stock appears to be undervalued.
The current stock price of NT$38.20 is trading 38.8% below its estimated GF Value™ of NT$62.38.
GuruFocus considers BenQ Medical Technology to be Significantly Undervalued.
Key valuation signals for ROCO:4116:
EBITDA Margin %: 13.19% (near median its 10-year median of 12.66)
GF Value™: NT$62.38 vs. price of NT$38.20 (38.8% below fair value)
Industry Position: 76.5% above the Medical Devices & Instruments median (#328 of 816)
No single metric tells the full story. See the ROCO:4116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BenQ Medical Technology Corp is engaged in the manufacturing, assembly, maintenance, repair, and sales of professional medical equipment and consumables. Its products include surgical and gynecology tables, digital OR solutions, halogen and LED surgical lights, and medical imaging products, among others. The company's segment includes the R&D and Manufacturing Division and the Medical Services Division. The company generates the majority of its revenue from the Medical Services Division. Geographically, the company generates revenue from Taiwan, Mainland China, Indonesia, Thai, India, Colombia, and Others.
81GF Score
Get the complete analysis for ROCO:4116
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4116 has been successfully added to your 
